Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation

• Asıl Yazarlar: Xiao-Jun Li (Yazar), Yan-Ni Wang (Yazar), Wen-Feng Wang (Yazar), Xiaoli Nie (Yazar), Hua Miao (Yazar), Ying-Yong Zhao (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

IntroductionIncreasing evidence shows that hyperactive aryl hydrocarbon receptor (AHR) signalling is involved in renal disease. However, no currently available intervention strategy is effective in halting disease progression by targeting the AHR signalling. Our previous study showed that barlerisid...